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Introduction
Hantavirus pulmonary syndrome (HPS) is an often fatal rodentborne zoonosis caused by any of at least 20 hantavirus genotypes distributed throughout the Americas. The disease was first identified in the USA where the newly described etiological agent, Sin Nombre virus (SNV), has caused approximately 600 cases with a fatality rate of 36%. 1 Although HPS is documented in several bordering countries, it has not been reported in Colombia.
In 2004, we detected IgG antibodies to SNV by ELISA in 14% of serum samples from 88 rural volunteers in north-western Colombia. 2 In 2013, we detected IgG antibodies to Maciel or Araraquara hantaviruses in 8.4% of 286 agricultural workers in Có rdoba Department. 3 These prevalences are much higher than those found in serosurveys in North America and suggest that rural workers in north-western Colombia are frequently exposed to one or more hantaviruses. [2] [3] [4] [5] Nevertheless, no HPS cases had been reported in Colombia.
Methods
In May 2013, a 26-year-old man from Montería, Colombia ( Figure 1 ) was admitted to the emergency ward (San Jeró nimo Hospital, Montería) complaining of fever, headache, arthralgia, myalgia, asthenia, malaise, and dyspnoea of 7-day duration. He was tested for regionally endemic agents, Plasmodium, Leptospira, Salmonella, dengue virus, Brucella, Rickettsia, human immunodeficiency virus and hepatitis viruses. Because the patient was enrolled in a clinical trial for hemorrhagic fevers conducted by the University of Có rdoba, serum samples were collected on admission and at discharge. These serum samples were tested by ELISA for antibodies reactive to SNV. The SNV ELISA detects (cross-reacts with), but does not distinguish between all known hantaviruses hosted by New World cricetid rodents. 
Results
The patient lived in a rural natural habitat bordering cultivated areas where people live alongside rodents and in poor sanitation conditions. On admission, he was febrile (40 8C) and had a heart rate of 76 beats/min and respiratory rate of 23 breaths/min. He had icteric sclera, no lymphadenopathy, normal cardiac and pulmonary auscultation findings, painful splenomegaly, no rash, and a normal neurological examination. A chest X-ray was normal. Pancytopenia and hyperbilirubinemia were seen on haematological analysis. Tests for regionally endemic agents in acute phase samples were all negative (Table 1 ). The patient remained febrile for 3 days; he was discharged on day 5 without a definitive diagnosis. ELISA testing of the stored admission and discharge sera showed IgG and IgM seroconversion to SNV. Tests for Leptospira, dengue virus, Brucella and Rickettsia repeated on convalescent samples were negative (Table 1 ).
Discussion
We did not find it unusual that the case patient did not have pulmonary oedema and only had a mild respiratory symptoms. In a study done in bordering Panama, 21% of diagnosed HPS patients did not show pulmonary oedema and 44% had mild HPS with mild oedema but no respiratory insufficiency. 6 The investigators in Panama described three categories of hantavirus infection: hantavirus fever (absence of dyspnoea, normal chest X-ray, not requiring oxygen therapy), mild HPS (occasional or no dyspnoea, abnormal chest X-ray), and moderate to severe HPS (marked dyspnoea, abnormal chest X-ray, mechanical ventilation required). 6 The present serologically confirmed HPS case is compatible with hantavirus fever, as described above. In Colombia we have observed other cases that are compatible with hantavirus fever, but none have been confirmed serologically. The rodents, Zygodontomys brevicauda (reservoir of Calabazo virus in Panama) and Oligoryzomys fulvescens (reservoir of Choclo virus, a known agent of HPS in Panama), are also found in adjacent Colombia, 7 including Có rdoba. In 2011, investigators from Antioquia Department (adjacent to Có rdoba) found 14% of sampled Z. brevicauda to be antibody-positive to SNV and Maciel viruses. 4 Sequencing of PCR amplicons from their lung tissue revealed a virus closely related to Calabazo virus from Panama. 4 This is the only report of the genetic characterization of a hantavirus in rodents in Colombia.
Confirmation of the case we describe was in accordance with one US Centers for Disease Control and Prevention laboratory criterion for the diagnosis of HPS -the detection of hantavirusspecific IgM or rising titres of hantavirus-specific IgG. 8 Nevertheless, hantavirus infection in humans in Colombia has not been diagnosed by culture or molecular techniques. The eventual finding of this first clinical case of hantavirus infection in Colombia is consistent with the high prevalence of hantavirus antibodies in humans in the region and the likely exposure of the patient to rodents. Furthermore, the clinical presentation was similar to that found in neighbouring Panama. 6 Finally, although there is strong evidence of a broad geographic distribution of HPS in the Americas and in neighbouring countries, 2-5,9 a high prevalence of hantavirus infection in local rodent populations, and associated risk factors for HPS (exposure to rural rodents), the apparent incidence of HPS in Colombia is low. One reason for this disparity is likely poor surveillance within Colombia. It is also possible that the strain of virus infecting humans in Colombia is relatively benign and only rarely causes symptomatic disease. The demonstration of HPS in Colombia is important information for Colombian public health and medical personnel; this case report should help physicians to suspect and diagnose HPS.
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